Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by CancerSlayeron Oct 21, 2024 8:42pm
236 Views
Post# 36275899

RE:Big Move..

RE:Big Move..
chry200030 wrote: If you think today was a big move, you have not seen anything yet !!
We are talking the cure for cancer here...
We WILL get days where we get a lot more than 100% gains.
Asking for all trades to be cancelled is just laughable.. HA HA Ha 


Agree...
This should be a legit big move as we establish a new base re: share price & investors.  When you consider the pointed content/confidence of that email as well as the recent escalation of positive NRs re: the data/science & outside interest, Big Pharma is likely sniffing around the edges like a K-9 to cocaine...

It's no secret that Pharma has been feeling the growing pressure of expiring patents & the tightening pinch of expensive manufacturing/operating costs (particularly for biologics).  Therefore, R&D expenses have to ratchet up & be streamlined as much as possible.  I can't think of a better solution than 
finding a more cost-effective drug/approach that will appease the payors (government, insurers & HMOs).  Our small molecule drug (SMD)/ACT provides a perfect opportunity imo.

Unlike many current treatments/biologics, an SMD is generally less expensive to manufacture, is generally more stable than biologics (i.e. lesser proclivity to degrade = sustained efficacy, long shelf-life, easier/less expensive handling & storage), is system/patient/treatment burden-friendly & can be a more cost-effective approach.  When you add on the potential of not only having a one-and-done or more versatile treatment, but also an SMD that has "multiple indication" potential, Pharma should be salivating at the margins & readying to open its warchest post BTD.  All imo.  Good times are arriving soon...

<< Previous
Bullboard Posts
Next >>